BioMarin Pharmaceutical Profile

USD 0.28  0.33%

BioMarin Pharmaceutical exotic insider transaction detected

BioMarin Pharmaceutical Inc insider trading alert for general transaction of stock option (right to buy common stock) by Bienaime Jean Jacques, Chief Executive Officer, on March 17, 2018. This event was filed by Biomarin Pharmaceutical I with SEC on 2014-04-01. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

BioMarin Pharmaceutical Summary

BioMarin Pharmaceutical Inc (BMRN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 2,581 people. BioMarin Pharmaceutical is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with current market capitalization of 15.13 B. BioMarin Pharmaceutical Inc conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 176.07 M outstanding shares of which 9.03 M shares are currently shorted by private and institutional investors with about 5.81 trading days to cover. BIOMARIN PHARMACE currently holds about 1.4 B in cash with (8.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.93.
Check BioMarin Pharmaceutical Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected BioMarin Pharmaceutical Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

BioMarin Pharmaceutical Against Markets

Current Ratings

BioMarin Pharmaceutical 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 8% 
Equity ratings for BioMarin Pharmaceutical Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
BioMarin Pharmaceutical, Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. The company was founded in 1996 and is headquartered in San Rafael, California. BioMarin Pharmaceutical operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 2581 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameBioMarin Pharmaceutical Inc
Chairman of the Board, CEOJeanJacques BienaimeView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address770 Lindaro Street
Foreign Associate  Austria
CIK Number01048477.0
IndustryPharmaceuticals And Biosciences
Contact Number415 506 6700
CurrencyUSD - US Dollar


BioMarin Pharmaceutical Analyst Recommendations
Target PriceAdvice# of Analysts
BioMarin Pharmaceutical Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
BioMarin Pharmaceutical Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


BioMarin Pharmaceutical Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.29April 27, 2017
BioMarin Pharmaceutical Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


BioMarin Pharmaceutical Corporate Directors
Elaine Heron Independent Director, MBA
Dennis Slamon Director, Ph.D
Robert Hombach Independent Director, MBA